Ebnet Medical - Innovating Vascular Access

Home
Solutions
Team
Investors
News
Contact

Home
Solutions
Team
Investors
News
Contact

Next-generation vascular access

Innovative technologies from medical experts
Next-generation vascular access

Simplicity

(Product not approved for commercial distribution)

Details
Next-generation vascular access

Innovation

(Product not approved for commercial distribution)

Details
Next-generation vascular access

Empathy

(Product not approved for commercial distribution)

Details

Next-Generation Vascular Access

Jens Ebnet, M.D., M.Sc., D.E.S.A.,

Founder and Managing Director, Specialist in Anesthesiology, Intensive Care and Emergency Medicine

We focus on the development of safe and cost-effective platform technologies (products not approved for commercial distribution) within the leading intellectual property portfolio for next-generation vascular access.

Vascular access is life-saving, with billions of catheters being used per year in a growing market.

Numerous studies describe very high complication rates with tremendous additional costs.

Up to 69% of common (peripheral) venous catheters fail.⁽¹⁾

Premature removal of common venous catheters leads to conservatively estimated additional costs of 1.5 billion US dollars per year in the US alone.⁽²⁾

In up to 54% of children, the vein is not successfully accessed on the first attempt.⁽³⁾

The annual costs resulting from unintentional dislodgement of common venous catheters amount to over 266 million US dollars in the US alone.⁽⁴⁾

We truly understand patient and user needs and focus on crucial improvements.

Products not approved for commercial distribution.

Products not approved for clinical use.

Jens Ebnet, M.D., M.Sc., D.E.S.A.,

We focus on the development of safe and cost-effective platform technologies (products not approved for commercial distribution) within the leading intellectual property portfolio for next-generation vascular access.

Vascular access is life-saving, with billions of catheters being used per year in a growing market.

Numerous studies describe very high complication rates with tremendous additional costs.

Up to 69% of common (peripheral) venous catheters fail.⁽¹⁾

Premature removal of common venous catheters leads to conservatively estimated additional costs of 1.5 billion US dollars per year in the US alone.⁽²⁾

In up to 54% of children, the vein is not successfully accessed on the first attempt.⁽³⁾

The annual costs resulting from unintentional dislodgement of common venous catheters amount to over 266 million US dollars in the US alone.⁽⁴⁾

We truly understand patient and user needs and focus on crucial improvements.

Products not approved for commercial distribution.

Products not approved for clinical use.

Jens Ebnet, M.D., M.Sc., D.E.S.A.,
Founder and Managing Director,
Specialist in Anesthesiology,
Intensive Care and
Emergency Medicine

Peripheral Vascular Harm among Top 10 Patients Safety Concerns in 2021⁽⁵⁾

Frequent

Peripheral Intravenous Catheter (PIVC) Insertion: the most commonly performed invasive procedure in hospitals worldwide, yet with a total error rate of up to 50% even in highly trained hands.⁽⁶⁾

Challenging

First attempt insertion failure rates of up to 26% in adults and up to 54% in children.⁽³⁾

Painful

The survivorship of Peripheral Intravenous Catheters (PIVCs) placed in hospitalized patients is shockingly poor and leads to frequent reinsertions.⁽⁷⁾

Costly

Avoiding PIVC reinsertions can save a 200-bed hospital over $980,000 annually.⁽⁸⁾
The Market size for PIVCs is estimated to be $5.7 Billion in 2022, with a projected market size of $11.3 Billion in 2032.⁽⁹⁾

Our Solutions (not approved for commercial distribution)

Ebnet Medical: Ebnüle PIVC peripheral intravenous catheter

EbnetPIVC

SwordCath^®

Midline Catheter

Non-Kinking Vascular Catheter

EbnetPIVC

SwordCath^®

Midline Catheter

Non-Kinking Vascular Catheter

Testimonials

“I have been supporting the learning of vascular cannulations in a pedagogical context for more than two decades and I am delighted that the innovations of Ebnet Medical will make skills needed for vital therapies easier, safer and reliable."

Roland MölgenSpecialist Nurse Intensive Care Medicine and Anesthesia, Professional Educator (Nursing B.A.), Adult Education (M.A.)

"Current practice in vascular cannulation presents a whole range of significant problems - some with life-threatening consequences. These unacceptable problems are the result of a lack of innovation as the medical devices and techniques used in this process have remained unchanged for many decades.

Ebnet Medical takes on the responsibility of improving this situation by developing pragmatic, medical technology innovations and bringing them to market. This is achieved by combining clinicians with practical experience from various professions with other experienced specialists such as designers, engineers, patent attorneys, MDR experts and investors."

Prof. Dr. med. Konstantinos RaymondosSpecialist in anesthesiology, intensive care and emergency medicine

"The safety and applicability of medical devices has been in my focus for many years. One of my professional goals is to reduce the frequency of incorrect punctures in everyday clinical practice. Here we can achieve relevant approvements by the use of ultrasound-assisted puncture techniques, training of medical staff, but especially by further development of innovative medical devices. These can increase safety in patient care and significantly improve patient comfort.

The product developments of Ebnet Medical seem to be suitable for optimizing the technical features for this in the future."

Privatdozent Dr. med. Matthias GöpfertSpecialist in anesthesiology, intensive care and emergency medicine

"During my years as an active anesthesia and intensive care nurse, I've had the privilege of gathering extensive experience with vascular catheters. Reflecting on this, I'm still surprised by the widespread acceptance among nurses and doctors regarding the limitations of long-established products.

It's time for a shift in perspective! I'm increasingly optimistic when I see the innovative solutions from Ebnet Medical. These solutions prioritize enhancing patient safety. With their smart features and user-friendly design, they offer the potential to streamline workflows, minimize complications, and save costs."

Isabel KlützkeClinical Nurse Specialist & Advisor

References

(1) Observational Study of Peripheral Intravenous Catheter Outcomes in Adult Hospitalized Patients: A Multivariable Analysis of Peripheral Intravenous Catheter Failure – Marsh – 2018 – Journal of Hospital Medicine – Wiley Online Library
(2) Improving Nurses’ Peripheral Intravenous Catheter Insertion Knowledge, Confidence, and Skills Using a Simulation-Based Blended Learning Program – PMC (nih.gov)
(3) Failed attempts and improvement strategies in peripheral intravenous catheterization – PubMed (nih.gov)
(4) Impact and Safety Associated with Accidental Dislodgement of Vascular Access Devices: A Survey of Professions, Settings, and Devices – ScienceDirect
(5) Racial, Ethnic Health Disparities Top Patient Safety Concern for 2021 (ecri.org)
(6) Accepted but unacceptable: peripheral IV catheter failure – PubMed (nih.gov)
(7) Doomed peripheral intravenous catheters: Bad Outcomes are similar for emergency department and inpatient placed catheters: A retrospective medicalrecord review – PubMed (nih.gov)
(8) Vascular access management (bd.com)
(9) Peripheral Intravenous Catheters Market Size & Forecast | FMI (futuremarketinsights.com)

Next-generation vascular access

Innovative technologies from medical experts
Next-generation vascular access

Simplicity

(Product not approved for commercial distribution)

Details
Next-generation vascular access

Innovation

(Product not approved for commercial distribution)

Details
Next-generation vascular access

Empathy

(Product not approved for commercial distribution)

Details

Next-Generation Vascular Access

We focus on the development of safe and cost-effective platform technologies (products not approved for commercial distribution) within the leading intellectual property portfolio for next-generation vascular access.

Vascular access is life-saving, with billions of catheters being used per year in a growing market.

Numerous studies describe very high complication rates with tremendous additional costs.

Up to 69% of common (peripheral) venous catheters fail.⁽¹⁾

Premature removal of common venous catheters leads to conservatively estimated additional costs of 1.5 billion US dollars per year in the US alone.⁽²⁾

In up to 54% of children, the vein is not successfully accessed on the first attempt.⁽³⁾

The annual costs resulting from unintentional dislodgement of common venous catheters amount to over 266 million US dollars in the US alone.⁽⁴⁾

We truly understand patient and user needs and focus on crucial improvements.

Products not approved for commercial distribution.

Products not approved for clinical use.

Jens Ebnet, M.D., M.Sc., D.E.S.A., Founder and Managing Director, Specialist in Anesthesiology, Intensive Care and Emergency Medicine